Ftse Mib
34.226,75
-0,43%
DAX
19.931,63
-0,36%
S&P 500
5.898,11
0,50%
NASDAQ
19.453,61
0,90%
Bitcoin
96.780,20
-0,12%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Reneo Pharmaceuticals Inc (RPHM) Reneo Pharmaceuticals Inc (RPHM) Notizie

RPHM

Reneo Pharmaceuticals (RPHM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RPHM
DataOraFonteTitoloSimboloCompagnia
10/12/202413:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RPHMReneo Pharmaceuticals Inc
10/12/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPHMReneo Pharmaceuticals Inc
09/12/202422:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RPHMReneo Pharmaceuticals Inc
07/11/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPHMReneo Pharmaceuticals Inc
31/10/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RPHMReneo Pharmaceuticals Inc
28/10/202421:03Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RPHMReneo Pharmaceuticals Inc
23/10/202423:03Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
21/10/202420:24Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RPHMReneo Pharmaceuticals Inc
11/10/202422:15Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202401:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202401:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
02/10/202423:23Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RPHMReneo Pharmaceuticals Inc
26/08/202412:10Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/08/202413:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
01/07/202421:13PR Newswire (US)Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law FirmNASDAQ:RPHMReneo Pharmaceuticals Inc
13/05/202413:35GlobeNewswire Inc.Reneo Pharmaceuticals and OnKure Announce Proposed MergerNASDAQ:RPHMReneo Pharmaceuticals Inc
07/05/202413:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
28/03/202412:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business UpdateNASDAQ:RPHMReneo Pharmaceuticals Inc
25/03/202412:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:RPHMReneo Pharmaceuticals Inc
05/02/202422:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RPHMReneo Pharmaceuticals Inc
14/12/202315:05GlobeNewswire Inc.Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202323:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202322:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPHMReneo Pharmaceuticals Inc
13/11/202313:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
02/11/202312:50GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:RPHMReneo Pharmaceuticals Inc
25/10/202313:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific MeetingsNASDAQ:RPHMReneo Pharmaceuticals Inc
09/10/202313:50GlobeNewswire Inc.Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)NASDAQ:RPHMReneo Pharmaceuticals Inc
06/10/202314:30GlobeNewswire Inc.Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro SummitNASDAQ:RPHMReneo Pharmaceuticals Inc
28/08/202323:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RPHMReneo Pharmaceuticals Inc
10/08/202313:35GlobeNewswire Inc.Reneo Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:RPHMReneo Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RPHM

La tua Cronologia

BIT
S29671
Societe Generale Effekten
BIT
P1R031
BNP Paribas Issuance
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network